Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (191-200 of 364) with videos related to

Pageof 37
Sort By:
Clinical and Diagnostic Laboratory Immunology|November 13, 2004
Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adultsJo Southern, Sarah Deane, Lindsey Ashton, et al.
Clinical and Vaccine Immunology : CVI|November 13, 2009
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccineRay Borrow, Nick Andrews, Helen Findlow, et al.
Journal of Medical Microbiology|June 1, 2013
Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assayNorman K Fry, David J Litt, John Duncan, et al.
Vaccine|October 22, 2022
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in EnglandShari Sapuan, Nick Andrews, Bassam Hallis, et al.
Elife|February 9, 2022
Inference of the SARS-CoV-2 generation time using UK household dataWilliam S Hart, Sam Abbott, Akira Endo, et al.
The Lancet. Infectious Diseases|March 24, 2022
Effectiveness of BNT162b2 against COVID-19 in adolescentsAnnabel A Powell, Freja Kirsebom, Julia Stowe, et al.
The Journal of Pain|June 1, 2022
If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of PsychedelicsRobert H Dworkin, Brian T Anderson, Nick Andrews, et al.
NIHR Open Research|February 11, 2025
Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-studyJonathan Broad, Dominic Sparkes, Naomi Platt, et al.
The Journal of Infectious Diseases|August 2, 2015
Rapid Declines in Age Group-Specific Rotavirus Infection and Acute Gastroenteritis Among Vaccinated and Unvaccinated Individuals Within 1 Year of Rotavirus Vaccine Introduction in England and WalesChristina J Atchison, Julia Stowe, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2020
Secondary Attack Rate and Family Clustering of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children of Healthcare Workers With Confirmed Coronavirus Disease 2019 (COVID-19)Shamez N Ladhani, Nick Andrews, Felicity Aiano, et al.
Pageof 37

Showing results (191-200 of 364) with videos related to

Sort By:
Pageof 37
Clinical and Diagnostic Laboratory Immunology|November 13, 2004
Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adultsJo Southern, Sarah Deane, Lindsey Ashton, et al.
Clinical and Vaccine Immunology : CVI|November 13, 2009
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccineRay Borrow, Nick Andrews, Helen Findlow, et al.
Journal of Medical Microbiology|June 1, 2013
Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assayNorman K Fry, David J Litt, John Duncan, et al.
Vaccine|October 22, 2022
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in EnglandShari Sapuan, Nick Andrews, Bassam Hallis, et al.
Elife|February 9, 2022
Inference of the SARS-CoV-2 generation time using UK household dataWilliam S Hart, Sam Abbott, Akira Endo, et al.
The Lancet. Infectious Diseases|March 24, 2022
Effectiveness of BNT162b2 against COVID-19 in adolescentsAnnabel A Powell, Freja Kirsebom, Julia Stowe, et al.
The Journal of Pain|June 1, 2022
If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of PsychedelicsRobert H Dworkin, Brian T Anderson, Nick Andrews, et al.
NIHR Open Research|February 11, 2025
Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-studyJonathan Broad, Dominic Sparkes, Naomi Platt, et al.
The Journal of Infectious Diseases|August 2, 2015
Rapid Declines in Age Group-Specific Rotavirus Infection and Acute Gastroenteritis Among Vaccinated and Unvaccinated Individuals Within 1 Year of Rotavirus Vaccine Introduction in England and WalesChristina J Atchison, Julia Stowe, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2020
Secondary Attack Rate and Family Clustering of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children of Healthcare Workers With Confirmed Coronavirus Disease 2019 (COVID-19)Shamez N Ladhani, Nick Andrews, Felicity Aiano, et al.
Pageof 37